. 2022 Feb 11;6(5):1032–1044. doi: 10.1002/hep4.1877
© 2021 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
FIG. 3.
Crude rate of LREs at the end of follow‐up among GEMS risk classes.